- Semi-Solid Formulations
- Liquid Formulations
- Solid Formulations
- Transdermal Products
The Topical Drug Delivery Market Size was valued at USD 317.8 billion in 2023 and is poised to grow at a significant CAGR of 9.3% over 2024-2030. Topical Drug Delivery medication delivery is known to be one of the most effective methods of drug delivery owing to its finest therapeutic benefits. The rising incidences of skin disease and related issues globally are the factors that contribute to the topical drug delivery market growth. Furthermore, increasing benefits of transdermal medicine such as low rejection rate, excellent ease of administration, and outstanding patient convenience and persistence, over oral and ingesting medications (medications for gastrointestinal toxicity) that result in nausea and vomiting, are pushing the demand for the topical drug delivery market. Additionally, due to its non-invasive nature, patches decreased the inconvenience brought on by parenteral or intravenous therapies is propelling the market growth. During covid 19, the topical drug delivery market is hit badly by lockdowns worldwide. That pandemic also hurt the supply and demand chain of raw materials needed to make medications (such as drugs and manufacturing equipment). On the brighter side, the global economy is projected to gradually normalize, with an increase in the manufacturing and transportation of raw materials and associated equipment, resulting in market growth.
Study Period
2024-2030Base Year
2023CAGR
9.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
People are more likely to develop skin infections such as eczema, psoriasis, and minor ailments including acne these are the key drivers for the topical drug delivery market. Furthermore, the growing incidences of burn injuries, the prevalence of diabetes and eye diseases, and the wide use of drugs to treat diabetic neuropathic pain and foot ulcers are also projected to have a progressive growth rate in the global market. Technical barriers associated with skin irritation and permeability are expected to challenge the topical drug delivery market in the forecast period. The topical drug delivery market is hindered by the presence of various alternative drug delivery modes for patients.
By Product Type
By Distribution Channel
By End User
Applying medication to the skin or mucous membranes allows it to enter the body from there. Medication applied in this way is known as a topical medication. It can also be used to treat pain or other diseases in specific parts of the body.
Transdermal products are administered to the skin and the drugs permeate into the systemic circulation and are sent throughout the body to the targeted section
Rising skin infections such as eczema, psoriasis, and minor ailments including acne and research and development in the healthcare infrastructure.
1. Executive Summary |
2. Global Topical Drug Delivery Market Introduction |
2.1. Global Topical Drug Delivery Market - Taxonomy |
2.2. Global Topical Drug Delivery Market -Definitions |
2.2.1. Product Type |
2.2.2. Route Of Administration |
2.2.3. Distribution channel |
2.2.4. End User |
2.2.5. Geography |
3. Global Topical Drug Delivery Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Topical Drug Delivery Market Dynamic Factors - Impact Analysis |
3.6. Global Topical Drug Delivery Market - Competition Landscape |
4. Global Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Topical Drug Delivery Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Semi-Solids Formulations |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Liquid Formulations |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Solids Formulations |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Transdermal Products |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Topical Drug Delivery Market, By Route Of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Dermal Drug Delivery |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ophthalmic Drug Delivery |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Rectal Drug Delivery |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Vaginal Drug Delivery |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Nasal Drug Delivery |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Topical Drug Delivery Market Forecast, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Retail |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Direct Tenders |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Topical Drug Delivery Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Clinics |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Hospitals |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Home Healthcare |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Diagnostics Centre’s |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Others |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. Global Topical Drug Delivery Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
10. North America Topical Drug Delivery market analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Semi-Solid Formulations |
10.1.2. Liquid Formulations |
10.1.3. Solid Formulations |
10.1.4. Transdermal Products |
10.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Dermal Drug Delivery |
10.2.2. Ophthalmic Drug Delivery |
10.2.3. Rectal Drug Delivery |
10.2.4. Vaginal Drug Delivery |
10.2.5. Nasal Drug Delivery |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Retail |
10.3.2. Direct Tenders |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Clinics |
10.4.2. Hospitals |
10.4.3. Home Healthcare |
10.4.4. Diagnostic Centers |
10.4.5. Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
10.7. North America Topical Drug Delivery Market Dynamics - Trends |
11. Europe Topical Drug Delivery Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Semi-Solid Formulations |
11.1.2. Liquid Formulations |
11.1.3. Solid Formulations |
11.1.4. Transdermal Products |
11.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Dermal Drug Delivery |
11.2.2. Ophthalmic Drug Delivery |
11.2.3. Rectal Drug Delivery |
11.2.4. Vaginal Drug Delivery |
11.2.5. Nasal Drug Delivery |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Retail |
11.3.2. Direct Tenders |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Clinics |
11.4.2. Hospitals |
11.4.3. Home Healthcare |
11.4.4. Diagnostic Centers |
11.4.5. Others |
11.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
11.7. Europe Topical Drug Delivery Market Dynamics - Trends |
12. Asia-Pacific Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Semi-Solid Formulations |
12.1.2. Liquid Formulations |
12.1.3. Solid Formulations |
12.1.4. Transdermal Products |
12.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Dermal Drug Delivery |
12.2.2. Ophthalmic Drug Delivery |
12.2.3. Rectal Drug Delivery |
12.2.4. Vaginal Drug Delivery |
12.2.5. Nasal Drug Delivery |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Retail |
12.3.2. Direct Tenders |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Clinics |
12.4.2. Hospitals |
12.4.3. Home Healthcare |
12.4.4. Diagnostic Centers |
12.4.5. Others |
12.5. Country Analysis2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
12.7. Asia-Pacific Topical Drug Delivery Market Dynamics - Trends |
13. Latin America Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2022-2028(Revenue, USD Mn) |
13.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Semi-Solid Formulations |
13.1.2. Liquid Formulations |
13.1.3. Solid Formulations |
13.1.4. Transdermal Products |
13.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Dermal Drug Delivery |
13.2.2. Ophthalmic Drug Delivery |
13.2.3. Rectal Drug Delivery |
13.2.4. Vaginal Drug Delivery |
13.2.5. Nasal Drug Delivery |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Retail |
13.3.2. Direct Tenders |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Clinics |
13.4.2. Hospitals |
13.4.3. Home Healthcare |
13.4.4. Diagnostic Centers |
13.4.5. Others |
13.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Argentina |
13.5.4. Rest of Latin America |
13.6. Latin America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
13.7. Latin America Topical Drug Delivery Market Dynamics - Trends |
14. Middle East and Africa Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Semi-Solid Formulations |
14.1.2. Liquid Formulations |
14.1.3. Solid Formulations |
14.1.4. Transdermal Products |
14.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Dermal Drug Delivery |
14.2.2. Ophthalmic Drug Delivery |
14.2.3. Rectal Drug Delivery |
14.2.4. Vaginal Drug Delivery |
14.2.5. Nasal Drug Delivery |
14.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Retail |
14.3.2. Direct Tenders |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Clinics |
14.4.2. Hospitals |
14.4.3. Home Healthcare |
14.4.4. Diagnostic Centers |
14.4.5. Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
14.7. MEA Topical Drug Delivery Market Dynamics - Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Johnson & Johnson Private Limited (U.S.) |
15.2.2. Allergan (Ireland) |
15.2.3. Nestlé India Ltd., (Switzerland) |
15.2.4. Merck & Co Inc., (U.S.) |
15.2.5. Novartis AG (Switzerland) |
15.2.6. GlaxoSmithKline plc (U.K) |
15.2.7. Bausch Health Companies Inc., (Canada) |
15.2.8. Bayer AG (Germany), |
15.2.9. Crescita Therapeutics (Canada) |
15.2.10. LEO Pharma A/S (Denmark) |
15.2.11. Hisamitsu Pharmaceutical Co., Inc. (Japan) |
15.2.12. Glenmark Pharmaceuticals Limited, (India) |
15.2.13. Cipla Inc., (India) |
15.2.14. Mylan N.V. (U.S.) |
15.2.15. Encore Dermatology, (U.S.) |
16. Research Methodology |
17. Key Assumptions and Acronyms |